RESUMO
Acrylamide has been employed as an experimental probe to investigate biochemical and morphological changes in developing rat liver following toxin administration in pregnant rats. Non-anesthetized pregnant rats were given acrylamide by gastric intubation at a dose of 10 mg/kg/day. The pups were divided into three groups: Group A, mothers were treated with saline (control group); Group B, mothers were treated with acrylamide from day D7 of gestation till birth (prenatal intoxication); Group C, mothers were treated with acrylamide from D7 of gestation to D28 after birth (perinatal intoxication). Acrylamide-induced biochemical changes (in liver and serum) and morphological changes (in liver) were studied in control and acrylamide-treated developing pups. Prenatally and perinatally administered acrylamide significantly increased lipid peroxidation and reduced glutathione and total thiol levels in liver. Significant inhibition of peroxidase and superoxide dismutase activities was observed in liver tissue. Total lipids including cholesterol and triglycerides were significantly increased in the serum. Acrylamide treatment increased serum alanine aminotransferase and aspartate aminotransferase activities and inhibited alkaline phosphatase activity. Sodium and potassium concentrations were increased, but calcium, phosphorus and iron levels were significantly reduced in the serum. Acrylamide produced significant electrophoretic changes in serum proteins. The most noticeable change was splitting of beta-globulin into beta1- and beta2-globulins. Light microscopy showed acrylamide-induced fatty deposits, congested central vein, vacuolization and chromatolysis in hepatocytes. Ultrastructural studies revealed vacuolated cytoplasm, lipid droplets of variable size and mitochondria with damaged cristae and vacuolization. The nuclei in acrylamide-treated groups showed marked decrease in the staining of nuclear DNA.
